Ambergen Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Ambergen

Access the complete profile.

Ambergen Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	44 Manning Rd Suite 105 Billerica, MA 01821

Note: Revenues for privately held companies are statistical evaluations.


Ambergen's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Ambergen's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Ambergen is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Ambergen Annual Revenue and Growth Rate

Ambergen	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Ambergen's revenues are gauged from an analysis of company filings.

Ambergen's Income Statement (based on Industry Averages)

Ambergen P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Ambergen has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
April 15, 2022	1	100%	$5 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Ambergen is developing and marketing. Ambergen doesn't have any recent trademark applications, indicating Ambergen is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AFFYTAG REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE, NAMELY, A MOLECULAR GROUP ADDED TO A BIOMOLECULE TO FACILITATE ITS CAPTURE ON A SURFACE OR ITS INTERACTION WITH ANOTHER MOLECULE	04/02/2002
AMBERGEN Specialty biological and biochemical reagents used for research, specifically, in vitro translations	10/21/1999

See all trademarks and details in the Full Report.

Market Share of Ambergen's Largest Competitors

A competitive analysis shows these companies are in the same general field as Ambergen, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Ambergen. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
SYSTEMS & TECHNOLOGY RESEARCH	Woburn, MA	100
TRANSMEDICS	Andover, MA	44
6K	North Andover, MA	35
PHYSICAL SCIENCES	Andover, MA	33
TRITON SYSTEMS	Chelmsford, MA	30
COVARIS	Woburn, MA	29

Future Competition: Ambergen's Fastest Growing Competitors

These companies are in the same general field as Ambergen and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)